You should not miss this annual opportunity if you are - Chiefs, Directors, Heads, Senior Manager, Leaders and Executives from:
-
Clinical Operations
-
Clinical Developments/Research
-
Clinical Trials/ Program/ Clinical Project/Operations
-
Study and Feasibility Management
-
Medical Operations/Monitoring Operations
-
International Clinical Research
-
Patient Recruitment & Retention
-
Medical Affairs/ Medical Advisors/ MSL
-
Data Management
-
Compliance and Regulatory
-
Patient Enrolment/ Patient Advocacy/ Patient Executive
-
Therapeutic Lead
-
Study Lead/ Study Delivery/ Study Director/PI
-
Clinical Site Management
-
Digital/Medical Technologies
For group discounts and complete details contact us.
WHO SHOULD ATTEND
CONFERENCE BENEFITS
-
Get engaged with the professionals from leading industries
-
20+ Keynote Sessions
-
5+ Workshop sessions
-
Round Table Discussions – Brain storming
-
Panel Discussions – Interact Directly with the Panellists to raise your challenges
-
More than 10 Case Studies presenting by the top experts from across the industry
-
13+ hours Networking Opportunity
-
Benchmarking Opportunities
-
One-to-one interactions
-
Tea/Coffee Breaks, Social Events and Cocktail Reception
-
.…and much more!
Opportunity to meet top expert and decision makers from Pharma, Biotech, Medical Devices, Clinical Sites and CROs industry under one Roof
OVERVIEW
BETTER STUDY PLANNING, BETTER DATA, BETTER PATIENTS, BETTER RESULTS.
Register till 20th December and SAVE 20%!! Discount Code: EB20DISC59
A rewarding opportunity to join OECT Summit in three key locations in Germany, Canada and USA.
OECT Summit is targeted for professionals who are always seeking for new opportunities, visionary ways of conducting performance. Study Feasibility and Patient recruitment & retention offer major challenges to the clinical researcher, clinical project managers, clinical operation managers with potential for significant impact on timelines, budgets, CRA talent rejuvenation, collaborations & partnerships and ultimately the scientific integrity of the trial itself.
Many factors affect the recruitment of patients and difficulty in finding suitable patients is driving the development of many innovative methods for accessing new patient groups. How ‘Big Data Analytics and Date Driven Decision Making’ can have a significant impact in clinical trials. The artificial intelligence, remote trials/ virtual trials, decentralised trials, connected health and digitalisation means that new technologies and changing strategies for communication can be used to engage patients at early development stage, have feasibility right at first, accelerate site selection initiation process & great effect to reach out to patients directly.
Additionally, outreach through patient advocacy groups, social service agencies are becoming more important to communicate with patients viable for trial participation as well as for those already enrolled in clinical trials. How to maximise the benefit of this approach and ensure our regulatory obligations are appropriately met will be the subject of several sessions during the summit.
Don’t forget to check our OECT Summit editions in Canada and USA.
KP Morgan specializes in clinical trials, SFE, commercial excellence and Healthcare innovation events, hosting events in various locations such as Canada, USA, Europe and Dubai.
KP-Morgan Conferences have provided platforms for debate across many industry sectors including: Telecommunication, banking & financial services, retail and FMCG, investments, pharmaceuticals, IT, chemical & petro chemical.
Many argue that the innovation process cannot be managed because innovation is supposed to be about creativity and cannot be predicted. We believe in KP-Morgan that Innovation is not only about being creative and inventive; innovation is a collaborative process where ideas are taken and managed through to value-adding market introduction.
The consistent high quality of our events has given rise to a reputation for excellence, ensuring that KP-Morgan conferences provide the most fertile ground for participants to gain up-to-the-minute market intelligence and invaluable opportunities to network and generate new business.
About KP-Morgan Group
AGENDA: TOPICS AT GLANCE
Keynote Presentation, Interactive Discussions, Case Studies, Brain Storming and Round Table Discussions
Study Feasibility, Study Site Operations, DHT's, DCTs and Patient Engagement
-
Engaging Sites and investigators: Optimizing Study Design
-
How to improve site relationship: Optimize CT operations and boost performance
-
Site Selection, Activation & Performance: Best Practices
-
Engaging Sites and Patients: study design,Site Selection Methodology
-
Complex of SOPs & eConsent
-
Changing Roles of Clinical Project Managers
-
Communication barriers in CROs, Sponsors & Sites: Key to successful partnership
-
Let's Make it work: Time, Quality, Budget & Rare Disease!
-
Rethinking the path to enrolment: Planning and Recruitment
-
Selecting Patient-Facing Technology: Why it is important for patient centric trials?
-
Patient Engagement and Retention Straregies
-
Diversity & Inclusion
-
Demonstrating Patient Insights at early drug development
-
Understanding technology advancement at patient level
-
Transforming Data and Data Driven Patient Recruitment
-
Holistic approach to patient recruitment ,Case Study: CNS, Rare Diseases Trials
-
Role of Technologies(ePRO, eTMF, EDC, CTMS) Digital Transformation(AI, DCTs) and Clinical Innovation
-
How DHTs(Digital Health Technology) advancing the clinical trials: Wearables, AI, Big Data Analytics, Telemedicine, Biomarkers, mobile apps
-
Intersecting Digital Health(wearables, mobile apps, Virtual Platforms) and Decentralized Clinical Trial Operations for Optimal Patient Outcomes
-
Solution to unmet clinical trial needs: Investigators perspective
-
Evolution of data science in data management
-
Data driven decision making
-
Leveraging RWD for Clinical Research
-
GCP challenges of using Connected Health solutions in clinical trials
-
Role of Sites, Site Engagement & Management
-
Central Vs Remote monitoring
-
From NCR to iPADs: CRA of the Future- Digital enabler
-
Cross functional KPIs
-
How data & Technology are changing the CPM role in Clinical Trials
-
Study Feasibility-Right at First
-
Study Oversight & Vendor Management Setup
-
Feasibility and protocol optimisation
-
Design Tools to effectively plan, manage and track your clinical study portfolio
-
Study Start-up & Resource Management
-
Study delivery: On-time and effectively
-
Trial Design, Regulatory aspects and Operations: Medical Device Perspectives
PATIENT EMPOWERMENT: AS PARTER
-
Diversity & Inclusion
-
How to retain patients in long run trials
-
Engaging Patients in Recruitment Strategies in Clinical Trial
-
Patient awareness program
-
Holistic approach to patient recruitment
-
Patient journey mapping
-
Case Study: Oncology Trials, Rare Diseases Trials, Diabetes Trials
-
Patient Centric Approaches
-
What role sites can play in patient recruitment
-
Role of Tech: What is means to patient?
-
Demonstrating Patient Insight from an early stage of drug development
-
Advancing use of patient centric platform trials
-
Patient Recruitment in Emerging countries and Challenges for Global Trials
-
Data driven patient recruitment
CLINICAL TECHNOLOGIES & TRENDS
-
eClinical Outcome Assessments/ePRO
-
(electronic Patient-Reported Outcome) Methods
-
A hybrid model for enablement of decentralized clinical trials and remote centralized monitoring (eSource)
-
How Technology & Real-time Data Can Enable Trial Success.
-
Role of wearables, AIs, Digitalisation, eHealth in clinical innovation
-
How to translate technology/databases knowledge into identification of patients
Frank Berger
Global Clinical Development & Operations |
Boehringer Ingelheim
Ariadna Masó
Founder & CEO |
Sanno
Teresa Diaz
Global Director - Drug Development Strategy | CEBIS CRO
Olga Martinez-Casares
Head Clinical Research Strategy | GSK
Wolfgang Summa
Head of CMO Informatics | Merck KGaA
Joanna Wilińska
Regional Operations Manager Poland |
GCP-Service International CRO
Jonathan Crowther
Director Site Intelligence |
Pfizer
Nigel Goodman
CEO |
Gaea OÜ CRO and Clinical Trial Acceleration
Thomas Paier
Senior Feasibility Strategist | Bayer
Luzia Steiner
Head of Clinical Monitoring and Clinical Project Management
Swiss Group for Clinical Cancer Research (SAKK)
Nadir Ammour
Global Lead, Clinical Innovation & Partnership | Sanofi
Ute Bertelsmann
Managing Director, Country Head Germany | Pratia
Juergen Bergemann
Director APAC Region & Business Transformation | Medtronic Clinical & Regulatory Solutions (MCRS)
Volker Haufe
Site Engagement Lead, Clinical Study Unit Germany – Austria – Switzerland
| Sanofi
Jo Burmester
CEO |
JoBurmester.com
Karin Schiene
Director, Strategic Feasibility and Analytics – Biopharm Team Lead | AstraZeneca
Tom Lazenby
Founder & CEO |
Mayet SaaS solution
Anna-Liisa Parts
COO
Menken Trials
Gerald Y. Minuk M.D.
Professor Emeritus | The University of Manitoba
co-founder of Refuah Solutions
Marlise Benz
Senior Director, Study Management, Late Development Oncology Clinical Operations| AstraZeneca
Panelist
Ulrika Axling
Clinical Trial Manager
Camurus
Panel Leader
Philippe Auby
Founder and CEO
auby philippe & partners
SPEAKERS AND PARTNERS
Well known industry leader and emerging talents
SAMPLE Speakers from 2024 edition
REGISTER
Basic
-
One Entry Pass to in-person Two days conference
-
Conference Material
-
Business Lunch
-
Tea and snacks
-
Cocktail Reception
Register till 20th December and SAVE 20%!! Discount Code: EB20DISC59
Premium
-
Two Entry Passes to Two days conference and pre-conference workshop
-
One complimentary pass
-
Business Lunch
-
Tea and snacks
-
Cocktail Reception